An open-label long-term Phase 3 study of CAM2029 in patients with acromegaly (ACROINNOVA 2): interim analysis of the subgroup of patients 'new to CAM2029' with controlled or uncontrolled acromegaly on standard-of-care treatment

Diego Ferone, Spencer-Segal Joanna L., Yaylali Guzin Fidan, Mirjana Doknic,Elena Isaeva,Alexander Dreval, Aleksandra Gilis-Januszewska, Emre Gezer, Irina Bancos, Laurence Katznelson, Maria Harrie, Agneta Svedberg, Pedroncelli Alberto M.,Fredrik Tiberg

Endocrine Abstracts（2024）

引用 0|浏览0

暂无评分

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要